Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Detection of β Thalassemia Carriers by Red Cell Parameters Obtained From the H2 Automatic Counter

This study is currently recruiting participants. (see Contacts and Locations)
Verified August 2015 by HaEmek Medical Center, Israel
Information provided by (Responsible Party):
Dr Koren Ariel, HaEmek Medical Center, Israel Identifier:
First received: May 31, 2007
Last updated: August 30, 2015
Last verified: August 2015
No Study Results Posted on for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: December 2016
  Estimated Primary Completion Date: December 2016 (Final data collection date for primary outcome measure)